Imazamethabenz inhibits human breast cancer cell proliferation, migration and invasion via combination with Pin1

Chen Liu1, Chaoyu Mu1, Zeng Li1

  • 1College of Pharmacy, Anhui Medical University, Hefei, Anhui 230032, P.R. China.

Insights

The herbicide imazamethabenz inhibits peptidyl-prolyl cis/trans isomerase, NIMA interacting‑1 (Pin1), a key marker in tumor development. This compound shows potential as an antitumor drug by inducing apoptosis and inhibiting breast cancer cell migration and invasion.

Area of Science:

  • Biochemistry
  • Oncology
  • Drug Discovery

Background:

  • Overexpression of peptidyl-prolyl cis/trans isomerase, NIMA interacting‑1 (Pin1) is linked to tumor occurrence and progression.
  • Pin1 plays a crucial role in cancer cell signaling pathways.

Purpose of the Study:

  • To investigate the potential of the herbicide imazamethabenz as an antitumor agent by targeting Pin1.
  • To elucidate the mechanism by which imazamethabenz affects cancer cells.

Main Methods:

  • Molecular docking and in vitro enzyme activity assays to confirm Pin1 inhibition.
  • MTT assays, western blotting, wound healing, and Matrigel invasion assays on MCF-7 breast cancer cells.

Main Results:

  • Imazamethabenz was confirmed to effectively inhibit Pin1 in vitro.
  • The compound induced apoptosis and suppressed migration and invasion in MCF-7 cells.
  • Inhibition of Pin1-mediated signaling pathways involving VEGF and MMP-9 was observed.

Conclusions:

  • Imazamethabenz demonstrates significant antitumor potential by inhibiting Pin1.
  • This herbicide offers a novel therapeutic strategy for treating Pin1-overexpressing tumors.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K